ICPAX | VENAX | ICPAX / VENAX | |
Total Expense Ratio | 1.50 | 0.09 | 1,667% |
Annual Report Gross Expense Ratio | 1.60 | 0.09 | 1,778% |
Fund Existence | 27 years | 21 years | - |
Gain YTD | 17.933 | 3.963 | 453% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 147M | 8.85B | 2% |
Annual Yield % from dividends | 0.59 | 3.06 | 19% |
Returns for 1 year | 20.17 | -1.46 | -1,381% |
Returns for 3 years | 45.17 | 11.98 | 377% |
Returns for 5 years | 200.65 | 203.28 | 99% |
Returns for 10 years | 46.66 | 33.76 | 138% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OBSIX | 28.95 | N/A | N/A |
Oberweis Small-Cap Opportunities Instl | |||
JLCVX | 78.43 | N/A | N/A |
JHancock Fundamental Large Cap Core R5 | |||
ETLAX | 15.91 | N/A | N/A |
Eventide Large Cap Focus A | |||
FCUEX | 20.51 | -0.10 | -0.49% |
NYLI PineStone U.S. Equity Class A | |||
BRZAX | 13.58 | -0.09 | -0.66% |
BlackRock Sust Aware Adg Intl Eq Inv A |